Green Cross (005250) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.074x

Based on the latest financial reports, Green Cross (005250) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩139.95 Billion ≈ $94.84 Million USD) by net assets (₩1.89 Trillion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Green Cross fund operations to measure how many days the company can operate on defensive assets alone.

Green Cross - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Green Cross's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Green Cross Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Green Cross ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Xinjiang West Animal Husbandry
SHE:300106
0.027x
Platinum Capital Ltd
AU:PMC
0.029x
Nordic Paper Holding AB
ST:NPAPER
0.115x
KS Terminals Inc
TW:3003
0.040x
Weyco Group Inc
NASDAQ:WEYS
0.072x
Dhani Services Limited
NSE:DHANI
0.010x
Cogstate Ltd
AU:CGS
0.235x
Elmera Group ASA
OL:ELMRA
-0.633x

Annual Cash Flow Conversion Efficiency for Green Cross (2000–2024)

The table below shows the annual cash flow conversion efficiency of Green Cross from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Green Cross market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩1.85 Trillion
≈ $1.26 Billion
₩-89.95 Billion
≈ $-60.96 Million
-0.049x -130.42%
2023-12-31 ₩1.88 Trillion
≈ $1.28 Billion
₩-39.65 Billion
≈ $-26.87 Million
-0.021x -142.67%
2022-12-31 ₩1.97 Trillion
≈ $1.33 Billion
₩97.16 Billion
≈ $65.84 Million
0.049x -9.05%
2021-12-31 ₩1.91 Trillion
≈ $1.29 Billion
₩103.77 Billion
≈ $70.32 Million
0.054x +154.07%
2020-12-31 ₩1.67 Trillion
≈ $1.13 Billion
₩35.77 Billion
≈ $24.24 Million
0.021x +320.95%
2019-12-31 ₩1.51 Trillion
≈ $1.02 Billion
₩7.65 Billion
≈ $5.18 Million
0.005x -80.40%
2018-12-31 ₩1.45 Trillion
≈ $984.76 Million
₩37.64 Billion
≈ $25.51 Million
0.026x -74.19%
2017-12-31 ₩1.44 Trillion
≈ $975.64 Million
₩144.48 Billion
≈ $97.91 Million
0.100x +17256.99%
2016-12-31 ₩1.38 Trillion
≈ $933.18 Million
₩-805.47 Million
≈ $-545.86K
-0.001x -110.87%
2015-12-31 ₩1.31 Trillion
≈ $885.99 Million
₩7.04 Billion
≈ $4.77 Million
0.005x -88.35%
2014-12-31 ₩1.18 Trillion
≈ $800.39 Million
₩54.54 Billion
≈ $36.96 Million
0.046x +189.06%
2013-12-31 ₩1.10 Trillion
≈ $745.23 Million
₩17.57 Billion
≈ $11.91 Million
0.016x -57.76%
2012-12-31 ₩972.83 Billion
≈ $659.27 Million
₩36.80 Billion
≈ $24.94 Million
0.038x -70.84%
2011-12-31 ₩895.76 Billion
≈ $607.04 Million
₩116.18 Billion
≈ $78.73 Million
0.130x -69.37%
2010-12-31 ₩839.83 Billion
≈ $569.14 Million
₩355.62 Billion
≈ $241.00 Million
0.423x -54.13%
2009-12-31 ₩522.78 Billion
≈ $354.28 Million
₩482.60 Billion
≈ $327.05 Million
0.923x +93.20%
2008-12-31 ₩350.47 Billion
≈ $237.51 Million
₩167.47 Billion
≈ $113.49 Million
0.478x -36.16%
2007-12-31 ₩351.08 Billion
≈ $237.92 Million
₩262.77 Billion
≈ $178.07 Million
0.748x +59.53%
2006-12-31 ₩221.73 Billion
≈ $150.26 Million
₩104.03 Billion
≈ $70.50 Million
0.469x +78.48%
2005-12-31 ₩236.96 Billion
≈ $160.59 Million
₩62.29 Billion
≈ $42.22 Million
0.263x -69.80%
2003-12-31 ₩210.22 Billion
≈ $142.46 Million
₩182.96 Billion
≈ $123.99 Million
0.870x +648.32%
2001-12-31 ₩273.93 Billion
≈ $185.64 Million
₩31.86 Billion
≈ $21.59 Million
0.116x -39.13%
2000-12-31 ₩282.15 Billion
≈ $191.21 Million
₩53.91 Billion
≈ $36.53 Million
0.191x --

About Green Cross

KO:005250 Korea Biotechnology
Market Cap
$342.58 Million
₩505.51 Billion KRW
Market Cap Rank
#14302 Global
#458 in Korea
Share Price
₩11250.00
Change (1 day)
-4.09%
52-Week Range
₩9680.00 - ₩17170.00
All Time High
₩51630.05
About

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more